Fisheries and reproductive biology of Octopus vulgaris (Mollusca: Cephalopoda) in the Gulf of Alicante (Northwestern Mediterranean)

The common octopus Octopus vulgarisCuvier, 1797 is the most fished cephalopod species along the Spanish coasts. Its catches are highly fluctuating due to the short life cycle of the species and to the annual variability of the recruitment pattern, strongly dependent on the environmental conditions affecting the eggs and paralarvae. This study examines the common octopus fishery, the catch composition, and the main features of the reproductive biology of this species in the Gulf of Alicante (Spanish Eastern coast, Western Mediterranean FAO division 37.1.1). The common octopus fishery was studied analysing the monthly landing and effort data by fishing gear from 1994 to 2005. Monthly samplings of the commercial O. vulgarislandings from trawlers and clay pots from January 2004 to December 2005 resulted in the measuring of 1833 specimens to enable analysis of the catch composition, and allowed the biological sampling of 1176 individuals to provide the reproductive parameters of the species in the study area. The length-weight relationship calculated for the species was BW = 0.51 * DML 2.87. The yearly sex ratios (males:females) were 1:1 (trawl, 2004), 1:0.74 (trawl, 2005), and 1:0.88 (clay pots, 2005). The size (dorsal mantle length, DML) at maturity of the species in the study area was 9.67 cm for males and 14.38 cm for females. The gonadosomatic index reached a peak between April and July for males and in July for females. The Fulton condition index was lower in both sexes between June and September, and for males in November-December, whereas for both sexes the values of the digestive gland index were at their maximum between June and December. The energy allocation between somatic and reproductive growth was investigated and the results suggested that the energy spent on reproduction mainly came from feeding, and not from energy stored in the mantle tissues or in the digestive glan

Biology (growth and reproduction) of the Mediterranean deep-water rose shrimp (Parapenaeus longirostris (Lucas, 1846), Crustacea, Decapoda) from the Alicante Gulf (s.e. Spain).

The deep-water rose shrimp (Parapenaeus longirostris) is a demersal species and an important resource for the trawl fishery in the Alicante Gulf (S.E. Spain). This paper describes, for first time in this area, certain biometric relationships, as well as growth parameters and reproductive patterns of the species. The results showed a sexual size dimorphism, with a negative allometry of relative growth and high rates of absolute growth, both particularly in males. However, females dominated in the catch proportion. The spawning period occurred throughout the year, but especially in June-July and in October-November and the maturation stage for females takes place within the second year of life

Age of spent Octopus vulgaris and stress mark analysis using beaks of wild individuals

Age estimation of the cephalopod Octopus vulgaris by using beaks has improved in recent years, but maximum age and longevity in the wild have not been confirmed due to the low availability of senescent wild octopuses. In this study, a beak analysis of lateral wall surfaces (LWS) from 20 spent specimens confirmed the one-year lifecycle of the species in Central East Atlantic waters. Stress marks (checks) were clearly located in the daily increment sequence of rostrum sagittal sections (RSS). The highest daily variations in sea surface temperature (ΔT) that occurred during the last months of their lifetimes coincided with the locations of the marks on the beak, enabling confirmation of O. vulgaris beaks as life recorders for the first time. It also supports the daily deposition of RSS beak increments in the wild. Individuals were grouped into two main zones, at 20ºN and 18ºN respectively. Both groups showed different thermal check patterns, in accordance with the oceanographic differences. Two other checks (not coinciding with high values of ΔT) were observed in RSS at averages of 15 and 28 days before death, respectively, which were interpreted as responding to senescent-related events.Instituto Espanol de Oceanografi

Some remarks on the angular momenta of galaxies, their clusters and superclusters

We discuss the relation between angular momenta and masses of galaxy structures base on the Li model of the universe with global rotation. In our previous paper (God{\l}owski et al 2002) it was shown that the model predicts the presence of a minimum in this relation. In the present paper we discuss observational evidence allowing us to verify this relation. We find null angular momentum J=0 for the masses corresponding to mass of galaxy grups and non-vanishing angular momenta for other galactic structures. We check these theoretical predictions analysing Tully's galaxy grups. The existing data comparing alignment in different galactic structure are consistent with obtained theoretical relation $J(M)$ if we interpret the groving alignment as the galactic increasing angular momenta in the galactic structure.Comment: 20 pages 1 figure. GRG accepte

ECOS-LINCE:A high-intensity heavy-ion facility for nuclear structure and reactions

During the last years, the ECOS working group has been considering the construction of a new high-intensity accelerator of stable ion beams for the next Long-Range Plan of the nuclear physics community in Europe. The new facility (LINCE) will be a multi-user facility dedicated to ECOS science: fundamental physics, astrophysics, nuclear structure and reaction dynamics. In this paper, we summarize preliminary design studies of the low-energy part of this facility based on the use of a multi-ion superconducting linac. [ABSTRACT FROM AUTHOR

Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials

Background: Randomised trials comparing the efficacy of standard endocrine therapy (ET) versus experimental ET + bevacizumab (Bev) in 1st line hormone receptor–positive patients with metastatic breast cancer have thus far shown conflicting results. Patients and methods: We pooled data from two similar phase III randomised trials of ET ± Bev (LEA and Cancer and Leukemia Group B 40503) to increase precision in estimating treatment effect. Primary end-point was progression-free survival (PFS). Secondary end-points were overall survival (OS), objective response rate (ORR), clinical benefit rate (CBR) and safety. Exploratory analyses were performed within subgroups defined by patients with recurrent disease, de novo disease, prior endocrine sensitivity or resistance and reported grades III–IV hypertension and proteinuria. Results: The pooled sample consisted of 749 patients randomised to ET or ET + Bev. Median PFS was 14.3 months for ET versus 19 months for ET + Bev (unadjusted hazard ratio [HR] 0.77; 95% confidence interval [CI] 0.66–0.91; p < 0.01). ORR and CBR with ET and ET + Bev were 40 versus 61% (p < 0.01) and 64 versus 77% (p < 0.01), respectively. There was no difference in OS (HR 0.96; 95% CI 0.77–1.18; p = 0.68). PFS was superior for ET + Bev for endocrine-sensitive patients (HR 0.68; 95% CI 0.53–0.89; p = 0.004). Grade III–IV hypertension (2.2 versus 20.1%), proteinuria (0 versus 9.3%), cardiovascular (0.5 versus 4.2%) and liver events (0 versus 2.9%) were significantly higher for ET + Bev (all p < 0.01). Hypertension and proteinuria were not predictors of efficacy (interaction test p = 0.33). Conclusion: The addition of Bev to ET increased PFS overall and in endocrine-sensitive patients but not OS at the expense of significant additional toxicity. Trials registration: ClinicalTrial.Gov NCT00545077 and NCT00601900

Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry

Objectives: Since the results of the RECOVERY trial, WHO recommendations about the use of corticosteroids (CTs) in COVID-19 have changed. The aim of the study is to analyse the evolutive use of CTs in Spain during the pandemic to assess the potential influence of new recommendations. Material and methods: A retrospective, descriptive, and observational study was conducted on adults hospitalised due to COVID-19 in Spain who were included in the SEMI-COVID- 19 Registry from March to November 2020. Results: CTs were used in 6053 (36.21%) of the included patients. The patients were older (mean (SD)) (69.6 (14.6) vs. 66.0 (16.8) years; p < 0.001), with hypertension (57.0% vs. 47.7%; p < 0.001), obesity (26.4% vs. 19.3%; p < 0.0001), and multimorbidity prevalence (20.6% vs. 16.1%; p < 0.001). These patients had higher values (mean (95% CI)) of C-reactive protein (CRP) (86 (32.7-160) vs. 49.3 (16-109) mg/dL; p < 0.001), ferritin (791 (393-1534) vs. 470 (236- 996) µg/dL; p < 0.001), D dimer (750 (430-1400) vs. 617 (345-1180) µg/dL; p < 0.001), and lower Sp02/Fi02 (266 (91.1) vs. 301 (101); p < 0.001). Since June 2020, there was an increment in the use of CTs (March vs. September; p < 0.001). Overall, 20% did not receive steroids, and 40% received less than 200 mg accumulated prednisone equivalent dose (APED). Severe patients are treated with higher doses. The mortality benefit was observed in patients with oxygen saturation </=90%. Conclusions: Patients with greater comorbidity, severity, and inflammatory markers were those treated with CTs. In severe patients, there is a trend towards the use of higher doses. The mortality benefit was observed in patients with oxygen saturation </=90%

RICORS2040 : The need for collaborative research in chronic kidney disease

Chronic kidney disease (CKD) is a silent and poorly known killer. The current concept of CKD is relatively young and uptake by the public, physicians and health authorities is not widespread. Physicians still confuse CKD with chronic kidney insufficiency or failure. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. Thus health authorities may consider CKD a non-issue: very few persons eventually need KRT and, for those in whom kidneys fail, the problem is 'solved' by dialysis or kidney transplantation. However, KRT is the tip of the iceberg in the burden of CKD. The main burden of CKD is accelerated ageing and premature death. The cut-off points for kidney function and kidney damage indexes that define CKD also mark an increased risk for all-cause premature death. CKD is the most prevalent risk factor for lethal coronavirus disease 2019 (COVID-19) and the factor that most increases the risk of death in COVID-19, after old age. Men and women undergoing KRT still have an annual mortality that is 10- to 100-fold higher than similar-age peers, and life expectancy is shortened by ~40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth greatest global cause of death by 2040 and the second greatest cause of death in Spain before the end of the century, a time when one in four Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded Centres for Biomedical Research (CIBER) network structure in Spain. Realizing the underestimation of the CKD burden of disease by health authorities, the Decade of the Kidney initiative for 2020-2030 was launched by the American Association of Kidney Patients and the European Kidney Health Alliance. Leading Spanish kidney researchers grouped in the kidney collaborative research network Red de Investigación Renal have now applied for the Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS) call for collaborative research in Spain with the support of the Spanish Society of Nephrology, Federación Nacional de Asociaciones para la Lucha Contra las Enfermedades del Riñón and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true